Slide 1Discovery of the Novel, Orally Active S1P 1 Receptor Agonist ACT-128800 (Ponesimod) Martin H. Bolli, Actelion Pharmaceuticals Ltd 3. Wädenswiler Chemie-Tag, 16. Juni…
